Impact of Cardiac Complications on Outcomes of Patients After Subarachnoid Hemorrhage

Subarachnoid Hemorrhage Clinical Trial

Official title:

Impact of Cardiac Complications on Outcomes of Patients After Subarachnoid Hemorrhage

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04177329
• Other study ID #: Impact of cardiac complication
• Status: Not yet recruiting
• Start date: December 1, 2019
• Est. completion date: December 1, 2020

Study information

• Verified date: November 2019
• Source: Assiut University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Patients with subarachnoid haemorrhage frequently develop cardiac complications affecting their outcome

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 50
• Est. completion date: December 1, 2020
• Est. primary completion date: May 31, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• Patients diagnosed as spontaneous subarachnoid hemorrhage.

• SSAH patients aged (18-70 years) of both sexes

Exclusion Criteria:

• History or current evidence of any CNS disease other than SAH which may cause cardiac complications.

• History or current evidence of medical illness as endocrinal and metabolic disorders which may cause cardiac complications

Related Conditions & MeSH terms

• Hemorrhage
• Subarachnoid Hemorrhage

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Electrocadriogram	to measure heart rate (beats/minute) in subarachnoid hemorrhage patients	1 miute
Primary	Echocardiogarphy	to measure ejection fraction (%) in subarachnoid hemorrhage patients	30 minute
Secondary	serum treponin level	to measure serum treponin(ng/ml)in subarachnoid hemorrhage patients	30 minute